|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 471/22 | (2006.01) |
| C07D 487/22 | (2006.01) | ||
| A61K 31/438 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3359542 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16778038.6 |
| Date of filing the European patent application | 2016-10-07 | |
| (97) | Date of publication of the European application | 2018-08-15 |
| (45) | Date of publication and mention of the grant of the patent | 2021-03-17 |
| (46) | Date of publication of the claims translation | 2021-05-25 |
| (86) | Number | PCT/EP2016/074008 |
| Date | 2016-10-07 |
| (87) | Number | WO 2017/060431 |
| Date | 2017-04-13 |
| (30) | Number | Date | Country code |
| 15189210 | 2015-10-09 | EP |
| (72) |
GOLLNER, Andreas, DE
BROEKER, Joachim, DE
KERRES, Nina, DE
KOFINK, Christiane, DE
RAMHARTER, Juergen, DE
WEINSTABL, Harald, DE
GILLE, Annika, DE
GOEPPER, Stefan, DE
HENRY, Manuel, DE
HUCHLER, Guenther, DE
|
| (73) |
Boehringer Ingelheim International GmbH,
Binger Strasse 173, 55216 Ingelheim am Rhein,
DE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | SpiroO[3H-indolo-3,2 -pirolidin]-2(1H)-ono junginiai ir dariniai, kaip MDM2-P53 inhibitoriai |
| SPIRO[3H-INDOLE-3,2 -PYRROLIDIN]-2(1H)-ONE COMPOUNDS AND DERIVATIVES AS MDM2-P53 INHIBITORS |
| Payment date | Validity (years) | Amount | |
| 2025-09-29 | 10 | 231.00 EUR |
| 2026-10-07 |